Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells
- PMID: 12771411
- DOI: 10.1099/vir.0.19055-0
Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells
Abstract
Endothelial cell-tropism- and leukocyte- (polymorphonuclear- and monocyte-) tropism (leukotropism) are two important biological properties shared by all recent clinical isolates of human cytomegalovirus (HCMV). These properties are lost during extensive propagation of HCMV isolates in human fibroblasts, as shown by reference laboratory-adapted strains AD169 and Towne. Here we show that strain AD169 may reacquire both properties in vitro, endothelial (both venous and arterial) cell-tropism preceding leukotropism (predominantly involving monocytes). Restriction fragment length polymorphism analysis and sequencing performed on the original virus inoculum from human fibroblasts and serial passages on endothelial cells confirmed virus identity. Thus, fundamental biological properties may be lost and reacquired in vitro according to the cell culture system employed. The lack of a 15 kb DNA fragment in the strain AD169 genome does not prevent the rescue of these biological functions, thus indicating that they are likely to be encoded by viral genes located elsewhere.
Similar articles
-
The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko- (neutrophil- and monocyte-) tropism in vitro.J Gen Virol. 2002 Aug;83(Pt 8):1993-2000. doi: 10.1099/0022-1317-83-8-1993. J Gen Virol. 2002. PMID: 12124463
-
Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome.J Gen Virol. 1999 Nov;80 ( Pt 11):2867-2877. doi: 10.1099/0022-1317-80-11-2867. J Gen Virol. 1999. PMID: 10580048
-
In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells.J Gen Virol. 2001 Jun;82(Pt 6):1429-1438. doi: 10.1099/0022-1317-82-6-1429. J Gen Virol. 2001. PMID: 11369888
-
A review of genetic differences between limited and extensively passaged human cytomegalovirus strains.Rev Med Virol. 2001 May-Jun;11(3):191-200. doi: 10.1002/rmv.315. Rev Med Virol. 2001. PMID: 11376481 Review.
-
Pathogenesis of human cytomegalovirus infection and cellular targets.Hum Immunol. 2004 May;65(5):381-6. doi: 10.1016/j.humimm.2004.02.009. Hum Immunol. 2004. PMID: 15172435 Review.
Cited by
-
The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.Cell Mol Immunol. 2015 Mar;12(2):170-9. doi: 10.1038/cmi.2014.120. Epub 2014 Dec 29. Cell Mol Immunol. 2015. PMID: 25544503 Free PMC article. Review.
-
Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.J Virol. 2016 Oct 28;90(22):10133-10144. doi: 10.1128/JVI.00463-16. Print 2016 Nov 15. J Virol. 2016. PMID: 27581989 Free PMC article.
-
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes.J Virol. 2004 Sep;78(18):10023-33. doi: 10.1128/JVI.78.18.10023-10033.2004. J Virol. 2004. PMID: 15331735 Free PMC article.
-
BST2/Tetherin enhances entry of human cytomegalovirus.PLoS Pathog. 2011 Nov;7(11):e1002332. doi: 10.1371/journal.ppat.1002332. Epub 2011 Nov 3. PLoS Pathog. 2011. PMID: 22072961 Free PMC article.
-
Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2.J Virol. 2011 Oct;85(19):10346-53. doi: 10.1128/JVI.00545-11. Epub 2011 Aug 3. J Virol. 2011. PMID: 21813614 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources